Cargando…
Daptomycin Therapy for Osteomyelitis: A Retrospective Study
BACKGROUND: Daptomycin is a rapidly bactericidal agent with broad coverage against Gram-positive organisms, including Staphylococcus aureus, the most frequent cause of osteomyelitis. The objective of this study was to describe the clinical outcome of patients with non-hardware associated osteomyelit...
Autores principales: | Gallagher, Jason C, Huntington, Jennifer A, Culshaw, Darren, McConnell, Scott A, Yoon, Minjung, Berbari, Elie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521200/ https://www.ncbi.nlm.nih.gov/pubmed/22691420 http://dx.doi.org/10.1186/1471-2334-12-133 |
Ejemplares similares
-
A retrospective study of outcomes of device-associated osteomyelitis treated with daptomycin
por: Hermsen, Elizabeth D., et al.
Publicado: (2016) -
Daptomycin: Local Application in Implant-Associated Infection and Complicated Osteomyelitis
por: Rosslenbroich, Steffen B., et al.
Publicado: (2012) -
Diagnosis of vertebral osteomyelitis
por: Maamari, Julian, et al.
Publicado: (2022) -
1507. Pharmacodynamic Target Attainment of Daptomycin Against Staphylococcus aureus for Treatment of Pediatric Osteomyelitis
por: Stimes, Grant, et al.
Publicado: (2019) -
Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs
por: Crompton, Jason A., et al.
Publicado: (2010)